FDA Orange Book · active-ingredient family
Meclofenamate sodium
Meclofenamate sodium is approved as 1 brand and 20 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:MECLOMEN · NDA 018006
1
Brand (NDA)
20
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MECLOMEN×2 | PARKE DAVIS | NDA 018006 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (20)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MECLOFENAMATE SODIUM | BARR | ANDA 072848 | — | Mar 20, 1989 | |
| MECLOFENAMATE SODIUM | BARR | ANDA 072809 | — | Mar 20, 1989 | |
| MECLOFENAMATE SODIUM | CHARTWELL RX | ANDA 072262 | — | Nov 29, 1988 | |
| MECLOFENAMATE SODIUM | CHARTWELL RX | ANDA 072263 | — | Nov 29, 1988 | |
| MECLOFENAMATE SODIUM | VITARINE | ANDA 071710 | — | Jun 15, 1988 | |
| MECLOFENAMATE SODIUM | VITARINE | ANDA 071684 | — | Jun 15, 1988 | |
| MECLOFENAMATE SODIUM | USL PHARMA | ANDA 071007 | — | Mar 25, 1988 | |
| MECLOFENAMATE SODIUM | USL PHARMA | ANDA 071008 | — | Mar 25, 1988 | |
| MECLOFENAMATE SODIUM | PAR PHARM | ANDA 072077 | — | Mar 10, 1988 | |
| MECLOFENAMATE SODIUM | PAR PHARM | ANDA 072078 | — | Mar 10, 1988 | |
| MECLOFENAMATE SODIUM | WATSON LABS | ANDA 071640 | — | Aug 11, 1987 | |
| MECLOFENAMATE SODIUM | WATSON LABS | ANDA 071641 | — | Aug 11, 1987 | |
| MECLODIUM | QUANTUM PHARMICS | ANDA 071380 | — | Jul 14, 1987 | |
| MECLODIUM | QUANTUM PHARMICS | ANDA 071381 | — | Jul 14, 1987 | |
| MECLOFENAMATE SODIUM×2 | ANI PHARMS | ANDA 071469 | — | Apr 15, 1987 | |
| MECLOFENAMATE SODIUM | AM THERAP | ANDA 071362 | — | Feb 10, 1987 | |
| MECLOFENAMATE SODIUM | AM THERAP | ANDA 071363 | — | Feb 10, 1987 | |
| MECLOFENAMATE SODIUM | WATSON LABS | ANDA 070400 | — | Nov 25, 1986 | |
| MECLOFENAMATE SODIUM | WATSON LABS | ANDA 070401 | — | Nov 25, 1986 | |
| MECLOFENAMATE SODIUM×2 | MYLAN | ANDA 071081 | — | Sep 03, 1986 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Meclofenamate sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

